NASDAQ:PRLD | Profit Breakdown | Prelude Therapeutics Inc

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$5.7M-$15.45M-$13.92M
2026-03-31$4.58M-$14.18M-$10.39M
2025-12-31$5.64M-$17.35M-$16.46M
2025-09-30$6.5M-$20.42M-$19.73M
2025-06-30$0.00-$32.19M-$31.23M
2025-03-31$0.00-$34.61M-$32.09M
2024-12-31$4M-$33.83M-$28.73M
2024-09-30$3M-$34.38M-$32.27M
2024-06-30-$37.16M-$34.74M
2024-03-31-$34.34M-$31.43M
2023-12-31-$37.38M-$33.08M
2023-09-30-$33.39M-$30.61M
2023-06-30-$32.4M-$30.43M
2023-03-31-$29.12M-$27.72M
2022-12-31-$33.39M-$28.64M
2022-09-30-$30.41M-$29.96M
2022-06-30-$29.46M-$27.37M
2022-03-31-$30.29M-$29.47M
2021-12-31-$33.01M-$32.84M
2021-09-30-$30.84M-$30.69M
2021-06-30-$27.92M-$26.87M
2021-03-31-$21.97M-$21.3M
2020-12-31-$19.45M-$19.25M
2020-09-30-$18.14M-$16.76M
2020-06-30-$11.44M-$11.41M
2020-03-31-$9.74M-$9.51M
2019-12-31-$10.1M-$10.04M
2019-09-30-$6.88M-$6.73M
2019-06-30-$5.56M
2019-03-31-$5.24M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$12.14M-$104.57M-$99.5M
2024-12-31$7M-$139.71M-$127.17M
2023-12-31-$132.28M-$121.83M
2022-12-31-$123.54M-$115.44M
2021-12-31-$113.74M-$111.69M
2020-12-31-$58.76M-$56.93M
2019-12-31-$28.11M-$27.57M